BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2545579)

  • 1. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
    Oda M; Ino Y; Suzuki K; Sato T; Iwamoto S; Iwaki M
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs].
    Oda M; Suzuki K; Ino Y; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):235-43. PubMed ID: 2545580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
    Ohmura I; Maki E; Naruse T; Ikeda N; Asami T; Sagawa N
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological comparison of captopril and MK-422 by a new method for measuring activity of angiotensin converting enzyme (ACE).
    Hidaka H; Sawada S; Sato R; Oka H; Yasuda Y
    Jpn Circ J; 1985 Nov; 49(11):1175-9. PubMed ID: 3005681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
    Malini PL; Strocchi E; Valtancoli G; Ambrosioni E
    J Clin Pharmacol; 1990 May; 30(5):422-4. PubMed ID: 2161435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
    Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ
    N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
    Kubo M; Kato J; Ochiai T; Ishida R
    Jpn J Pharmacol; 1990 Jun; 53(2):201-10. PubMed ID: 2200918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
    Ino Y; Oda M; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):219-24. PubMed ID: 2545578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
    Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T
    Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570).
    Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M
    Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
    J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.